Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
Criscitiello C, Viale G, Curigliano G, et al. Profile ofbuparlisib and its potential in the treatment of breast cancer:evidence to date. Breast Cancer (Dove Med Press).2018;10:23–29.On page 23, Giuseppe Curigliano’s affiliation was incorrcectlylisted as European Institute of Onco...
Guardado en:
Autores principales: | Criscitiello C, Viale G, Curigliano G, Goldhirsch A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cf53a45a28df41ae9d9237ca439bd00c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date
por: Criscitiello C, et al.
Publicado: (2018) -
Profile of neratinib and its potential in the treatment of breast cancer
por: Feldinger K, et al.
Publicado: (2015) -
Cryoablation In The Management Of Breast Cancer: Evidence To Date
por: Pusceddu C, et al.
Publicado: (2019) -
Clinical evidence of the efficacy of everolimus and its potential in the treatment of breast cancer
por: Saksena R, et al.
Publicado: (2013) -
Palbociclib: an evidence-based review of its potential in the treatment of breast cancer
por: Cadoo KA, et al.
Publicado: (2014)